Industry Updates

Arena Gets October FDA Deadline | Xconomy02 Mar

The big date is coming for local biotech Arena and its obesity
management candidate lorcaserin. October 22 is the date by which the
FDA will review their application and determine whether Arena has a
viable product or if it’s back to the drawing board. Either way it
will be a big turning point for the company, and exciting times for
San Diego biotech.

Leave a Reply

Company News

  • - 2013/03/04

    One of our team members is now working with Hospira on infuser product support. Contact us to find out more!

  • - 2010/10/24

    We're currently working with online elections provider Everyone Counts, Inc. Contact us to find out more!

Contact Us